Biopharma Co.'s Lies Caused Investor Losses, Suit Claims
Biopharmaceutical company Spero Therapeutics Inc. has been hit with a proposed class action suit from an investor who claims the company made false and misleading statements about the regulatory approval of...To view the full article, register now.
Already a subscriber? Click here to view full article